WST
WEST PHARMACEUTICAL SERVICES INCCompany Information
- Company Name
- WEST PHARMACEUTICAL SERVICES INC
- CIK
- CIK0000105770
- Category
- Large accelerated filer
- Ticker: Exchange
- WST: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- WST
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-09-15
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 14,372
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 67,478,160
- Shares outstanding
- 70,800,000
- Ownership
- 95.31%
Earnings Market Reaction
- Filing date
- 2026-07-23
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 436 | 521 | 791 | 629 | 510 | 404 | 485 | 491 | 446 | 602 | 854 | 899 | ||||||
| Accounts Receivable Net Current | 712 | 686 | 574 | 625 | 582 | 544 | 553 | 524 | 479 | 524 | 512 | 519 | ||||||
| Inventory Net | 447 | 453 | 444 | 438 | 421 | 389 | 377 | 401 | 419 | 430 | 435 | 432 | ||||||
| Other Assets Current | 212 | 167 | 169 | 132 | 168 | 121 | 124 | 134 | 138 | 137 | 136 | 123 | ||||||
| Assets Current | 1,808 | 1,827 | 1,978 | 1,823 | 1,681 | 1,458 | 1,538 | 1,551 | 1,483 | 1,693 | 1,936 | 1,972 | ||||||
| Property Plant And Equipment Gross | 3,249 | 3,223 | 3,223 | 3,233 | 3,178 | 3,005 | 2,986 | 2,991 | 2,864 | 2,791 | 2,738 | 2,607 | ||||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 1,562 | 1,521 | 1,497 | 1,492 | 1,456 | 1,374 | 1,404 | 1,420 | 1,370 | 1,343 | 1,325 | 1,296 | ||||||
| Property Plant And Equipment Net | 1,686 | 1,702 | 1,726 | 1,741 | 1,722 | 1,632 | 1,582 | 1,571 | 1,494 | 1,449 | 1,413 | 1,312 | ||||||
| Operating Lease Right Of Use Asset | 105 | 110 | 117 | 98 | 104 | 103 | 105 | 108 | 110 | 97 | 99 | 97 | ||||||
| Investments In Affiliates Subsidiaries Associates And Joint Ventures | 208 | 209 | 212 | 221 | 225 | 212 | 202 | 218 | 198 | 203 | 210 | 195 | ||||||
| Goodwill | 109 | 109 | 110 | 111 | 111 | 108 | 106 | 109 | 107 | 108 | 109 | 107 | ||||||
| Intangible Assets Net Excluding Goodwill | 6 | 7 | 8 | 9 | 10 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | ||||||
| Deferred Income Tax Assets Net | 72 | 64 | 38 | 28 | 30 | 26 | 26 | 38 | 34 | 21 | 26 | 17 | ||||||
| Other Assets Noncurrent | 83 | 81 | 80 | 76 | 71 | 70 | 74 | 69 | 50 | 19 | 21 | 39 | ||||||
| Assets | 4,076 | 4,110 | 4,270 | 4,106 | 3,953 | 3,618 | 3,643 | 3,675 | 3,489 | 3,602 | 3,830 | 3,755 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 253 | 252 | 254 | 256 | 239 | 228 | 239 | 224 | 212 | 240 | 242 | 220 | ||||||
| Accrued Income Taxes Current | 65 | 79 | 28 | 33 | 29 | 22 | 32 | 33 | 17 | 17 | 17 | 15 | ||||||
| Operating Lease Liability Current | 21 | 21 | 23 | 21 | 21 | 22 | 18 | 20 | 20 | 18 | 18 | 17 | ||||||
| Accrued Liabilities Current | 34 | 47 | - | - | - | - | - | - | - | - | - | - | ||||||
| Other Liabilities Current | 171 | 202 | 215 | 213 | 223 | 186 | 188 | 159 | 169 | 174 | 155 | 137 | ||||||
| Liabilities Current | 641 | 674 | 655 | 635 | 605 | 527 | 550 | 517 | 634 | 648 | 672 | 534 | ||||||
| Long Term Debt Noncurrent | 203 | 203 | 203 | 203 | 203 | 203 | 203 | 203 | 73 | 73 | 73 | 152 | ||||||
| Deferred Income Tax Liabilities Net | 22 | 23 | 23 | 23 | 23 | 21 | 21 | 9 | 14 | 13 | 13 | 17 | ||||||
| Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent | 28 | 29 | 29 | 31 | 31 | 29 | 28 | 30 | 29 | 29 | 30 | 28 | ||||||
| Operating Lease Liability Noncurrent | 88 | 92 | 96 | 74 | 80 | 79 | 82 | 82 | 85 | 82 | 85 | 83 | ||||||
| Deferred Compensation Liability Classified Noncurrent | 14 | 12 | 14 | 14 | 13 | 11 | 15 | 15 | 16 | 19 | 19 | 18 | ||||||
| Other Liabilities Noncurrent | 90 | 88 | 75 | 75 | 70 | 66 | 62 | 67 | 63 | 58 | 59 | 55 | ||||||
| Liabilities | 1,086 | 1,119 | 1,094 | 1,054 | 1,024 | 935 | 961 | 923 | 913 | 922 | 949 | 887 | ||||||
Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | ||||||
| Additional Paid In Capital | 0 | 0 | 0 | 0 | 0 | 2 | 22 | 23 | 34 | 55 | 120 | 123 | ||||||
| Retained Earnings Accumulated Deficit | 4,624 | 4,476 | 4,375 | 4,262 | 4,139 | 4,031 | 3,957 | 3,857 | 3,721 | 3,624 | 3,523 | 3,416 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -140 | -125 | -106 | -102 | -89 | -206 | -258 | -136 | -217 | -192 | -144 | -223 | ||||||
| Treasury Stock Common Value | -1,512 | -1,379 | -1,112 | -1,127 | -1,140 | -1,163 | -1,057 | -1,011 | -980 | -825 | -638 | -466 | ||||||
| Stockholders Equity | 2,990 | 2,990 | 3,176 | 3,052 | 2,929 | 2,683 | 2,682 | 2,752 | 2,577 | 2,681 | 2,881 | 2,868 | ||||||
| Liabilities And Stockholders Equity | 4,076 | 4,110 | 4,270 | 4,106 | 3,953 | 3,618 | 3,643 | 3,675 | 3,489 | 3,602 | 3,830 | 3,755 | ||||||
| Preferred Stock Shares Authorized | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | ||||||
| Shares Outstanding | 70 | 71 | 72 | 72 | 72 | 72 | 72 | 73 | 73 | 73 | 74 | 74 | ||||||
| Treasury Stock Common Shares | 5 | 4 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 2 | 2 | 1 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialWEST PHARMACEUTICAL SERVICES INC (WST) — SEC Financial Statements & Analysis
WEST PHARMACEUTICAL SERVICES INC (WST) is a surgical & medical instruments & apparatus company, incorporated in PA. WEST PHARMACEUTICAL SERVICES INC trades on NYSE as: WST. WEST PHARMACEUTICAL SERVICES INC (WST)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-23. Based on that filing, WEST PHARMACEUTICAL SERVICES INC carries a market cap of $25.40B, a P/E ratio of 44.96x, a P/B ratio of 8.49x, a P/S ratio of 7.64x, an enterprise value of $25.17B, and an EV/EBITDA multiple of 29.29x. On profitability, it posts a gross margin of 36.79%, an operating margin of 20.45%, a net margin of 16.98%, a Return on Equity (ROE) of 19.09%, a Return on Assets (ROA) of 14.07%, and a Return on Invested Capital (ROIC) of 19.58%. Per share, it reports EPS of $7.98, diluted EPS of $7.92, free cash flow per share of $6.17, and a dividend per share of $0.88. Over the trailing year, it posted revenue growth of 12.38% year-over-year, net income growth of 15.83% year-over-year, and EPS growth of 18.12% year-over-year. On the balance sheet, it maintains a current ratio of 2.82x, a quick ratio of 2.12x, working capital of $1.17B, a debt-to-equity ratio of 0.36x, a debt ratio of 0.27, an interest coverage ratio of 138.86x, free cash flow of $436.90M (TTM), and net debt of $-232.90M. Figures sourced from SEC EDGAR.
- Market Cap
- $25.40B
- P/E TTM
- 44.96x
- EPS TTM
- $7.98
- P/B TTM
- 8.49x
- ROE TTM
- 19.09%
- ROA TTM
- 14.07%
- Debt To Equity
- 0.36x
- Free Cash Flow TTM
- $436.90M
- Net Revenue TTM Growth 1Y
- 12.38%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is WEST PHARMACEUTICAL SERVICES INC in?
WEST PHARMACEUTICAL SERVICES INC (WST) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does WST trade on?
WEST PHARMACEUTICAL SERVICES INC (WST) trades on the NYSE.
Where is WEST PHARMACEUTICAL SERVICES INC incorporated?
WEST PHARMACEUTICAL SERVICES INC is incorporated in PA.
When was WEST PHARMACEUTICAL SERVICES INC (WST)'s most recent SEC filing?
WEST PHARMACEUTICAL SERVICES INC (WST)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-23.
What is WST's market cap?
WEST PHARMACEUTICAL SERVICES INC (WST) has a market capitalization of $25.40B as of 2026-06-30.
What is WST's P/E ratio?
WEST PHARMACEUTICAL SERVICES INC (WST)'s trailing twelve month P/E ratio is 44.96x as of 2026-06-30.
What is WST's EPS (earnings per share)?
WEST PHARMACEUTICAL SERVICES INC (WST)'s trailing twelve month EPS is $7.98 as of 2026-06-30.
What is WST's ROE (return on equity)?
WEST PHARMACEUTICAL SERVICES INC (WST)'s trailing twelve month Return on Equity (ROE) is 19.09% as of 2026-06-30.
What is WST's ROA (return on assets)?
WEST PHARMACEUTICAL SERVICES INC (WST)'s trailing twelve month Return on Assets (ROA) is 14.07% as of 2026-06-30.
What is WST's ROIC (return on invested capital)?
WEST PHARMACEUTICAL SERVICES INC (WST)'s trailing twelve month Return on Invested Capital (ROIC) is 19.58% as of 2026-06-30.
What is WST's EV/EBITDA?
WEST PHARMACEUTICAL SERVICES INC (WST)'s trailing twelve month EV/EBITDA is 29.29x as of 2026-06-30.